Cardiovascular & Hematological Agents in Medicinal Chemistry
Title:Meet Our Editorial Board Member
Volume: 16 Issue: 1
Author(s): P.G. Baraldi
Affiliation:
Export Options
About this article
Cite this article as:
Baraldi P.G. , Meet Our Editorial Board Member, Cardiovascular & Hematological Agents in Medicinal Chemistry 2018; 16 (1) . https://dx.doi.org/10.2174/187152571601180910092838
DOI https://dx.doi.org/10.2174/187152571601180910092838 |
Print ISSN 1871-5257 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6182 |
Call for Papers in Thematic Issues
Medicinal Plants with Beneficial Properties on Diabetes and Hypertension
Diabetes and hypertension are real scourges of the 21st century. It is imperative to act in order to find innovative solutions to this problem. Taking medications such as hypoglycemic and antihypertensive drugs may aggravate certain underlying comorbidities, such as chronic kidney disease and cardiovascular disease. This significant drawback therefore requires ...read more
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Chemical Senses Affecting Cough and Swallowing
Current Pharmaceutical Design Statins And Stroke
Current Medicinal Chemistry 3D Ultrasound Imaging of the Carotid Arteries
Current Drug Targets - Cardiovascular & Hematological Disorders MicroRNAs-Based Therapeutic Strategy for Virally Induced Diseases
Current Drug Discovery Technologies A Century of Thioxanthones: Through Synthesis and Biological Applications
Current Medicinal Chemistry Levetiracetam might act as an efficacious drug to attenuate cognitive deficits of Alzheimer’s disease
Current Topics in Medicinal Chemistry Vascular Inflammation in Cardiovascular Disease: Is Immune System Protective or Bystander?
Current Pharmaceutical Design Lipoprotein-associated Phospholipase A2 and Coronary Heart Disease
Current Pharmaceutical Design Reduction in Estimated Glomerular Filtration Rate (eGFR) Results in an Increased Risk of Spontaneous Hemorrhagic Transformation in Patients with Large-artery Atherosclerosis Stroke
Current Neurovascular Research Triazol-phenyl Antipyretic Derivatives Inhibit mPGES-1 mRNA Levels in LPS-Induced RAW 264.7 Macrophage Cells
Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry The Use of Novel Oral Anticoagulants in Atrial Fibrillation
Cardiovascular & Hematological Disorders-Drug Targets <i>Salvia aucheri</i> Exhibits Antihypertensive Activity in Hypertensive Rats
Cardiovascular & Hematological Agents in Medicinal Chemistry Cell Sources in Cardiac Tissue Engineering: Current Choices
Current Stem Cell Research & Therapy Proteasome as an Emerging Therapeutic Target in Cancer
Current Pharmaceutical Design PSEN1 Promoter Demethylation in Hyperhomocysteinemic TgCRND8 Mice is the Culprit, not the Consequence
Current Alzheimer Research Leukotrienes and Atherosclerosis
Current Drug Targets Emerging Anticoagulant Therapies for Atrial Fibrillation: New Options, New Challenges
Current Medicinal Chemistry Signaling Pathways Involved in Neuron-Astrocyte Adhesion and Migration
Current Molecular Medicine Genetic Signatures in the Treatment of Stroke
Current Pharmaceutical Design EDITORIAL (Thematic Issue: Novel Oral Anticoagulation-A Milestone in Anticoagulation History)
Cardiovascular & Hematological Disorders-Drug Targets